Marc H. Glickman serves as Executive at Hancock Jaffe Laboratories, Inc., where they oversee executive responsibilities. Since joining the company, Marc H. Glickman has executed 2 insider transactions totaling $9.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 30, 2021 involved receiving (via award) 100,000 shares valued at $0.
Marc H. Glickman currently holds 101,600 shares of Hancock Jaffe Laboratories, Inc. (HJLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc H. Glickman has been a net buyer of HJLI stock. They have purchased $9.4K and sold $0 worth of shares.
Marc H. Glickman's most recent insider trade was on Nov 30, 2021, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $5.90 |
| Discretionary |